Biotechnology - , England, United Kingdom
Nightstar Therapeutics plc (NASDAQ: NITE) is a leading clinical-stage gene therapy company focused on developing and commercializing novel one-time treatments for patients suffering from rare inherited retinal diseases including choroideremia, X-linked retinitis pigmentosa and Best vitelliform macular dystrophy.
Outlook
Amazon CloudFront
Amazon Elastic Load Balancer
Route 53
Microsoft Office 365